AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2011
Dec 19, 2011
31542_dirs_2011-12-19_35e7f807-a3f7-4400-a6c7-c626641c6187.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2011-12-16
Reporting Person: O'Keeffe Charles B (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-12-16 | Options to purchase common stock | $1.07 | A | 30000 | Acquired | 2016-12-16 | Common Stock (30000) | Direct |
More from CATALYST PHARMACEUTICALS, INC.
Merger & Acquisition
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6